Hashimoto's thyroiditis — also known as Hashimoto's disease or chronic lymphocytic thyroiditis — is an autoimmune condition in which the body's immune system mistakenly attacks the thyroid gland. It is the most common cause of hypothyroidism in the United States and one of the most common autoimmune diseases overall.
What Happens in Hashimoto's Disease?
In Hashimoto's, the immune system produces antibodies — primarily thyroid peroxidase antibodies (TPO-Ab) and thyroglobulin antibodies (TgAb) — that attack the thyroid gland. Over time, this immune attack causes inflammation (thyroiditis) and progressive destruction of thyroid tissue, gradually reducing the gland's ability to produce hormones.
This process typically unfolds over months to years. Early on, the thyroid may release stored hormone as cells are damaged, temporarily causing thyrotoxicosis (elevated thyroid hormones). Eventually, as thyroid tissue is destroyed, the gland becomes underactive, resulting in hypothyroidism.
Who Is at Risk?
Hashimoto's can affect anyone, but certain factors increase risk:
- Sex: Women are 7–10 times more likely to develop Hashimoto's than men
- Age: Most commonly diagnosed between ages 30 and 50
- Family history: Autoimmune thyroid disease runs in families
- Other autoimmune diseases: Type 1 diabetes, rheumatoid arthritis, lupus, and other autoimmune conditions increase risk
- Pregnancy: Postpartum thyroiditis is a related condition
Symptoms
Early Hashimoto's may cause no symptoms at all. As the disease progresses and hypothyroidism develops, symptoms include fatigue, weight gain, cold intolerance, constipation, dry skin, hair loss, depression, brain fog, and irregular periods. A goiter (enlarged thyroid) may also develop, though it is usually painless.
💡 Note: Some people with elevated Hashimoto's antibodies have normal thyroid function for years or even decades. The presence of antibodies does not automatically mean treatment is needed — regular monitoring is key.
Diagnosis
Diagnosis is confirmed by blood tests showing elevated thyroid antibodies, combined with TSH and free T4 measurements. Thyroid ultrasound typically shows a characteristic heterogeneous ("patchy") appearance of the gland with reduced echogenicity; however, routine thyroid ultrasound is not generally indicated in Hashimoto's thyroiditis.
Treatment
Treatment of Hashimoto's thyroiditis focuses on managing hypothyroidism when it develops. Levothyroxine (synthetic T4) is the standard treatment. There is currently no treatment proven to stop the autoimmune process itself.
Patients with Hashimoto's and normal thyroid function require regular TSH monitoring (typically annually) so that treatment can be started promptly if hypothyroidism develops.
Some small studies suggest that selenium supplementation may reduce TPO antibody levels in Hashimoto's thyroiditis; however, the ATA and AACE guidelines do not recommend routine selenium supplementation for thyroid conditions, and excess selenium can be harmful. Similarly, a gluten-free diet has been advocated by some patient communities but is not supported by current endocrinology society guidelines as a treatment for Hashimoto's. These approaches should only be discussed with and supervised by your endocrinologist, and should not replace standard thyroid hormone therapy if it is indicated.
Key Takeaways
- Hashimoto's is the most common cause of hypothyroidism — it is an autoimmune attack on the thyroid
- Elevated TPO antibodies in blood is the diagnostic hallmark
- Not everyone with Hashimoto's needs treatment — it depends on thyroid hormone levels
- Regular monitoring is essential even when thyroid function is currently normal
- Levothyroxine effectively treats the hypothyroidism that develops